Oncology Institute (TOI) Revenue & Revenue Breakdown
Oncology Institute Revenue Highlights
Latest Revenue (Y)
$502.73M
Latest Revenue (Q)
$147.44M
Main Segment (Y)
Health Care, Patient Service
Oncology Institute Revenue by Period
Oncology Institute Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $502.73M | 27.79% |
| 2024-12-31 | $393.41M | 21.33% |
| 2023-12-31 | $324.24M | 28.42% |
| 2022-12-31 | $252.48M | 24.37% |
| 2021-12-31 | $203.00M | 8.26% |
| 2020-12-31 | $187.51M | 20.66% |
| 2019-12-31 | $155.41M | 37.33% |
| 2018-12-31 | $113.16M | - |
Oncology Institute generated $502.73M in revenue during NA 2025, up 27.79% compared to the previous quarter, and up 268.10% compared to the same period a year ago.
Oncology Institute Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $147.44M | 3.86% |
| 2025-12-31 | $141.96M | 3.95% |
| 2025-09-30 | $136.56M | 13.99% |
| 2025-06-30 | $119.80M | 14.75% |
| 2025-03-31 | $104.41M | 4.13% |
| 2024-12-31 | $100.27M | 0.37% |
| 2024-09-30 | $99.90M | 1.34% |
| 2024-06-30 | $98.58M | 4.13% |
| 2024-03-31 | $94.67M | 10.35% |
| 2023-12-31 | $85.79M | 4.57% |
| 2023-09-30 | $82.03M | 2.26% |
| 2023-06-30 | $80.22M | 5.29% |
| 2023-03-31 | $76.19M | 6.68% |
| 2022-12-31 | $71.42M | 9.92% |
| 2022-09-30 | $64.98M | 6.66% |
| 2022-06-30 | $60.92M | 10.44% |
| 2022-03-31 | $55.16M | 5.46% |
| 2021-12-31 | $52.30M | 0.06% |
| 2021-09-30 | $52.27M | 4.88% |
| 2021-06-30 | $49.84M | 2.60% |
| 2021-03-31 | $48.58M | -0.79% |
| 2020-12-31 | $48.97M | 3.63% |
| 2020-09-30 | $47.25M | -0.06% |
| 2020-06-30 | $47.28M | 7.40% |
| 2020-03-31 | $44.02M | 17.83% |
| 2018-12-31 | $37.36M | - |
Oncology Institute generated $147.44M in revenue during Q1 2026, up 3.86% compared to the previous quarter, and up 147.05% compared to the same period a year ago.
Oncology Institute Revenue Breakdown
Oncology Institute Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Health Care, Patient Service | $228.99M | $204.88M | $213.50M | $166.78M | $124.07M |
| Capitated Revenue | $80.48M | $68.69M | $70.37M | $61.34M | $54.28M |
| Fee For Service | $148.51M | $136.20M | $143.13M | $105.44M | $69.79M |
| Clinical Research Trials And Other Revenue | $4.56M | $8.61M | $6.90M | $6.36M | $6.38M |
| Dispensary Revenue | - | $179.92M | $103.83M | $79.34M | $72.55M |
Oncology Institute's latest annual revenue breakdown by segment (product or service), as of Dec 25: Health Care, Patient Service (49.51%), Fee For Service (32.11%), Capitated Revenue (17.40%), and Clinical Research Trials And Other Revenue (0.99%).
Quarterly Revenue by Product
| Product/Service | Mar 26 | Dec 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Health Care, Patient Service | $59.09M | $120.03M | $55.89M | $53.07M | $102.68M | $49.75M | $52.45M | $109.81M | $53.43M | $50.27M | $47.99M | $44.63M | $39.11M | $35.06M |
| Fee For Service | $32.16M | $75.89M | $37.05M | $35.57M | $66.47M | $34.94M | $34.79M | $72.79M | $36.64M | $33.70M | $31.47M | $28.27M | $25.16M | $20.54M |
| Capitated Revenue | $26.93M | $44.14M | $18.84M | $17.50M | $36.21M | $14.81M | $17.67M | $37.02M | $16.79M | $16.57M | $16.53M | $16.36M | $13.94M | $14.52M |
| Clinical Research Trials And Other Revenue | $813.00K | $1.18M | $1.34M | $2.04M | $4.14M | $1.94M | $2.53M | $3.62M | $1.60M | $1.68M | $1.82M | $1.51M | $1.59M | $1.43M |
| Dispensary Revenue | - | - | $62.57M | $49.29M | $92.03M | $48.21M | $39.68M | $54.40M | $25.20M | $24.24M | $21.61M | $18.84M | $20.22M | $18.68M |
Oncology Institute's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Health Care, Patient Service (49.66%), Fee For Service (27.02%), Capitated Revenue (22.63%), and Clinical Research Trials And Other Revenue (0.68%).
Oncology Institute Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AGL | Agilon Health | $5.93B | $1.44B |
| EHAB | Enhabit | $1.06B | $264.80M |
| CCRN | Cross Country Healthcare | $1.05B | $241.06M |
| AUNA | Auna | $1.04B | $286.20M |
| TOI | Oncology Institute | $502.73M | $147.44M |
| SNDA | Sonida Senior Living | $381.14M | $122.63M |
| EOLS | Evolus | $294.96M | $72.75M |
| KIDS | OrthoPediatrics | $236.35M | $59.36M |
| TMCI | Treace Medical Concepts | $212.69M | $47.20M |
| CBLL | CeriBell | $89.06M | $26.49M |
| AUTL | Autolus Therapeutics | $75.56M | $26.22M |